| Chronic hepatitis B a guideline to diagnosis, approach, management, and follow-up 2007 Turkish association for the study of liver | ULUS SALİH AKARCA | 207–230 |
| Hepatit B' de tanı, tedavi ve takip: 2007 yılı hepatit B konsensus toplantısı raporu | Ulus Salih AKARCA | 207–230 |
| Hepatocellular carcinoma pathogenesis: Does PPAR alpha polymorphism have a role in hepatocarcinogenesis associated with HBV and HCV infections? | Hikmet AKKIZ | 231–233 |
| Hepatosellüler karsinoma patogenezi: PPAR alpha polimorfizmi HBV ve HCV infeksiyonu ile birlikte olan hepatokarsinogeneziste rol oynayabilir mi? | Hikmet AKKIZ | 231–233 |
| Bone mineralization in children with inflammatory bowel disease: What is the role of zinc? | İNCİ NUR SALTIK TEMİZEL,Makbule EREN,HÜLYA DEMİR,NURAY USLU KIZILKAN,YUSUF USTA,HASAN ÖZEN,Figen GÜRAKAN,Aysel YÜCE | 234–238 |
| Does the severity of tissue eosinophilia of colonic neoplasms reflect their malignancy potential? | Şafak KIZILTAŞ,Sezgin Saime RAMADAN,AHMET TOPUZOĞLU,Sevgi KÜLLÜ | 239–244 |
| PPAR-alpha L162V polymorphism in human hepatocellular carcinoma | Elif Sare KOYTAK,Dilşa MIZRAK,Mehmet BEKTAŞ,HASİBE VERDİ,AYÇA ARSLAN ERGÜL,Ramazan İDİLMAN,Kubilay ÇINAR,Cihan YURDAYDIN,Sadık ERSÖZ,Kaan KARAYALÇIN,Özden UZUNALİMOĞLU,Hakan BOZKAYA | 245–249 |
| The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC | Nevin ORUÇ,Janette LAMB,David C. WHITCOMB,David A. SASS | 250–253 |
| The relationship between chronic HCV infection and the level of plasma adiponectin | Kadir AKSÖZ,Belkıs ÜNSAL,Adnan KIRCI,Emrah ALPER,Zafer BUYRAÇ,FATİH ASLAN,Cem ÇEKİÇ,Onur CENGİZ,Özcan Fulya ARI,Zeyra AKPINAR | 254–257 |
| Surgical management of Mirizzi syndrome | Ünal AYDIN,Pınar YAZICI,İsmail ÖZSAN,Galip ERSÖZ,Ömer ÖZÜTEMİZ,Murat ZEYTUNLU,Ahmet ÇOKER | 258–263 |
| Multifocal intestinal stromal tumors with jejunal perforation and intra-abdominal abscess: Report of a case | Erdal KARAGÜLLE,EMİN TÜRK,Erkan YILDIRIM,H.Savaş GÖKTÜRK,Halil KIYICI,Gökhan MORAY |